Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by 18ffds Petct

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT05611892CompletedPrimary

Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients

Showing all 1 trials

Research Network

Common Treatments

  • 18ffds Petct1

Active Sponsors

  • Johns Hopkins University1
  • National Institutes of Health (NIH)1

Top Investigators

Related Conditions

  • Oncologic Disease1
  • Inflammatory Disease1
  • Invasive Fungal Infections1

Activity Timeline